Taguchi M, Kondo H, Inoue Y, Kawahata Y, Jinbo Y, Sakamoto F, Tsukamoto G
New Drug Research Laboratories, Kanebo Ltd., Osaka, Japan.
J Med Chem. 1992 Jan;35(1):94-9. doi: 10.1021/jm00079a011.
A series of 8-substituted-9,1-(epoxymethano)-7-fluoro-5-oxo-5H- thiazolo[3,2-a]quinoline-4-carboxylic acids having a novel tetracyclic structure was synthesized and tested for antibacterial activity. The nature of the heteroatom (N, O, or S) substituted at the 8-position had little influence on the antibacterial activity. Among the six pyrrolidinyl derivatives and the five piperazinyl derivatives, the 8-(3-hydroxy-1-pyrrolidinyl) derivative 6h and the hydrochloride of the 8-(4-methyl-1-piperazinyl) derivative 6l showed the most potent activity against both Gram-positive and Gram-negative bacteria. Against nalidixic acid resistant strains, isolated from Escherichia coli KC-14, compound 6h was less potent than 6l. Replacement of the piperazinyl nitrogen atom by a carbon atom, an oxygen atom, or a sulfur atom (corresponding to the piperidino, morpholino, or thiomorpholino group, respectively) enhanced the activity against Gram-positive bacteria, but reduced the activity against Gram-negative bacteria. Compound 6l also showed potent in vivo antibacterial activity against Gram-positive and Gram-negative bacteria, and did not cause convulsions in mice with the concomitant administration of fenbufen. Replacement of the carboxy group by a sulfonic acid group in 6l resulted in a complete loss of antibacterial activity.
合成了一系列具有新型四环结构的8-取代-9,1-(环氧亚甲基)-7-氟-5-氧代-5H-噻唑并[3,2-a]喹啉-4-羧酸,并对其抗菌活性进行了测试。8位取代的杂原子(N、O或S)的性质对抗菌活性影响很小。在六种吡咯烷基衍生物和五种哌嗪基衍生物中,8-(3-羟基-1-吡咯烷基)衍生物6h和8-(4-甲基-1-哌嗪基)衍生物6l的盐酸盐对革兰氏阳性菌和革兰氏阴性菌均表现出最强的活性。对于从大肠杆菌KC-14分离出的耐萘啶酸菌株,化合物6h的活性低于6l。将哌嗪基氮原子分别用碳原子、氧原子或硫原子取代(分别对应于哌啶基、吗啉基或硫代吗啉基)可增强对革兰氏阳性菌的活性,但会降低对革兰氏阴性菌的活性。化合物6l对革兰氏阳性菌和革兰氏阴性菌也表现出有效的体内抗菌活性,并且在与芬布芬同时给药时不会引起小鼠惊厥。在6l中用磺酸基取代羧基会导致抗菌活性完全丧失。